Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium-Reference-Cited by-同舟云学术

Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium

Published:2019-07-09 Issue: Volume:10 Page:
ISSN:1664-0640
Container-title:Frontiers in Psychiatry
language:
Short-container-title:Front. Psychiatry

Author:

Arteaga-Henríquez Gara,Simon Maria S.,Burger Bianka,Weidinger Elif,Wijkhuijs Annemarie,Arolt Volker,Birkenhager Tom K.,Musil Richard,Müller Norbert,Drexhage Hemmo A.

Publisher

Frontiers Media SA

Subject

Psychiatry and Mental health

Reference100 articles.

1. Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis;Müller;Prog Neuropsychopharmacol Biol Psychiatry,1993

2. Depression, stress and immunological activation: the role of cytokines in depressive disorders;Connor;Life Sci,1998

3. Anhedonic and anxiogenic effects of cytokine exposure;Anisman;Adv Exp Med Biol,1999

4. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis;Mikova;Eur Neuropsychopharmacol,2001

5. Th1, Th2, and Th3 cytokine alterations in major depression;Myint;J Affect Disord,2005

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between immune-inflammation-based prognostic index and depression: An exploratory cross-sectional analysis of NHANES data;Journal of Affective Disorders;2024-10

2. “Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression;Pharmacological Research;2024-09

3. Continuous theta burst stimulation for bipolar depression: A multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites;Journal of Affective Disorders;2024-09

4. Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment;Journal of Psychopharmacology;2024-08-07

5. Recurrent COVID-19-related psychotic disorder with neuro-immuno-endocrine dysfunction as a possible underlying mechanism: A case report from China;Brain, Behavior, & Immunity - Health;2024-08